SJ733
/ Eisai, University of Kentucky
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 30, 2026
This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria
(clinicaltrials.gov)
- P2 | N=104 | Not yet recruiting | Sponsor: R. Kiplin Guy | Initiation date: Jul 2026 ➔ Oct 2026
Trial initiation date • Infectious Disease • Malaria
May 29, 2026
This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria
(clinicaltrials.gov)
- P2 | N=104 | Not yet recruiting | Sponsor: R. Kiplin Guy | Initiation date: Mar 2026 ➔ Jul 2026
Trial initiation date • Infectious Disease • Malaria
1 to 2
Of
2
Go to page
1